Intercept 213 EU Study
This app is intended to be used by patients enrolled in Intercept's 213 EU study
About Intercept 213 EU Study
This telemedicine app is intended to be used by patients enrolled in Intercept's 213 EU study. The purpose of this app is to connect patients and clinician's for the purpose of Intercept's study. Patients will use this app to schedule and conduct telemedicine calls.
This app is intended for users who are age 18 and over.
Similar Apps
Validation STD Participant app
Standard participant app for validation...
valinfra500 - app
app for only MDM testing...
Imago CTP-203 (PV)
Reach out to clinician for access....
Konfident302
The Konfident302 clinical trial app is designed to enable participants to complete...
Sanofi VAS00006 HARMONIE
A Patient App for the Sanofi VAS00006 HARMONIE Study. This app is...
Vedanta VE202002
A clinical study app for subjects in the Vedanta VE202002 study.This app...